|
RWDD2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.448400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.598000E-03 |
| Normal-vs-Stage2 |
1.220570E-01 |
| Normal-vs-Stage3 |
5.431700E-04 |
| Normal-vs-Stage4 |
1.821960E-01 |
| Stage1-vs-Stage2 |
9.973600E-01 |
| Stage1-vs-Stage3 |
3.803900E-02 |
| Stage1-vs-Stage4 |
8.805400E-01 |
| Stage2-vs-Stage3 |
1.389580E-01 |
| Stage2-vs-Stage4 |
8.966800E-01 |
| Stage3-vs-Stage4 |
2.828200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.83390000000028E-05 |
| Normal-vs-AfricanAmerican |
1.890610E-01 |
| Normal-vs-Asian |
3.244000E-01 |
| Caucasian-vs-AfricanAmerican |
1.985500E-02 |
| Caucasian-vs-Asian |
9.347400E-01 |
| AfricanAmerican-vs-Asian |
4.392800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.080200E-03 |
| Normal-vs-Female |
6.794300E-04 |
| Male-vs-Female |
2.033000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.827900E-04 |
| Normal-vs-Extreme_Weight |
2.064600E-03 |
| Normal-vs-Obese |
3.942400E-02 |
| Normal-vs-Extreme_Obese |
1.612590E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.140000E-01 |
| Normal_Weight-vs-Obese |
2.037600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.096000E-01 |
| Extreme_Weight-vs-Obese |
4.929200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.417000E-01 |
| Obese-vs-Extreme_Obese |
5.493600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.672300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.560200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.793900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.064100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.824200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.285000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.882200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.440190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.091200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.380000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.304300E-02 |
| Normal-VS-Type2 PRCC |
6.08989999999476E-05 |
| Normal-VS-KIRP CIMP |
2.178400E-04 |
| Normal-VS-Unclassified PRCC |
1.245590E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.189820E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.334200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.834800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.197600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.343800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.098400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.260590E-03 |
| Normal-vs-N1 |
3.72459999999908E-05 |
| Normal-vs-N2 |
9.219100E-03 |
| N0-vs-N1 |
3.220200E-01 |
| N0-vs-N2 |
5.846600E-01 |
| N1-vs-N2 |
9.039400E-01 |
|
|
